市場調查報告書

皰疹治療的全球市場:2020年∼2024年

Global Herpes Treatment Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 951865
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
皰疹治療的全球市場:2020年∼2024年 Global Herpes Treatment Market 2020-2024
出版日期: 2020年07月09日內容資訊: 英文 120 Pages
簡介

皰疹治療的全球市場在2020年∼2024年間,預測將成長到6億7702萬美元,在預測期間內預計將以4%的年複合成長率增長。

市場成長的主要因素有皰疹感染者數的增加,患者人數的增加以及老年人帶狀皰疹的患病率上升。

本報告提供皰疹治療的世界市場調查,提供市場形勢和規模,波特的五力分析,各類型的市場區隔,客戶和各地區形勢,業者情勢,供應商分析等資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:2019年∼2024年的預測

波特的五力分析

市場區隔:各類型

  • 市場區隔
  • 各類型比較
  • 帶狀皰疹:市場規模與預測(2019年∼2024年)
  • 單純皰疹:市場規模與預測(2019年∼2024年)
  • 各類型的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2019年∼2024年)
  • 歐洲:市場規模與預測(2019年∼2024年)
  • 亞洲:市場規模與預測(2019年∼2024年)
  • 其他地區:市場規模與預測(2019年∼2024年)
  • 主要國家
  • 各地區的市場機會
  • 市場成長要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 競爭模式
  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Eli Lilly and Co.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Maruho Co. Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

附錄

目錄
Product Code: IRTNTR44343

Technavio has been monitoring the herpes treatment market and it is poised to grow by $ 677.02 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period. Our reports on herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of herpes infection, large patient pool and rising prevalence rate of shingles in the older population. In addition, increasing prevalence of herpes infection is anticipated to boost the growth of the market as well.

The herpes treatment market analysis includes type segment and geographic landscapes

Technavio's ‘herpes treatment market ’ is segmented as below:

By Type:

  • Herpes zoster
  • Herpes simplex

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the emergence of novel therapies as one of the prime reasons driving the herpes treatment market growth during the next few years. Also, increasing focus on vaccine development and increasing focus on drug development for pre-adolescent patients will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our herpes treatment market covers the following areas:

  • Herpes treatment market sizing
  • Herpes treatment market forecast
  • Herpes treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading herpes treatment market vendors that include Bausch Health Companies Inc., Cipla Inc., Eli Lilly and Co., Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck & Co. Inc., Mylan NV, Novartis AG, and Teva Pharmaceutical Industries Ltd.. Also, the herpes treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Herpes zoster - Market size and forecast 2019-2024
  • Herpes simplex - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive Scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Eli Lilly and Co.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Maruho Co. Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Type - Market share 2019-2024 (%)
  • 22: Comparison by Type
  • 23: Herpes zoster - Market size and forecast 2019-2024 ($ million)
  • 24: Herpes zoster - Year-over-year growth 2019-2024 (%)
  • 25: Herpes simplex - Market size and forecast 2019-2024 ($ million)
  • 26: Herpes simplex - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Type
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Bausch Health Companies Inc. - Overview
  • 48: Bausch Health Companies Inc. - Business segments
  • 49: Bausch Health Companies Inc. - Key offerings
  • 50: Bausch Health Companies Inc. - Key customers
  • 51: Bausch Health Companies Inc. - Segment focus
  • 52: Cipla Inc. - Overview
  • 53: Cipla Inc. - Business segments
  • 54: Cipla Inc. - Key offerings
  • 55: Cipla Inc. - Key customers
  • 56: Cipla Inc. - Segment focus
  • 57: Eli Lilly and Co. - Overview
  • 58: Eli Lilly and Co. - Business segments
  • 59: Eli Lilly and Co. - Key offerings
  • 60: Eli Lilly and Co. - Key customers
  • 61: Eli Lilly and Co. - Segment focus
  • 62: Gilead Sciences Inc. - Overview
  • 63: Gilead Sciences Inc. - Product and service
  • 64: Gilead Sciences Inc. - Key offerings
  • 65: Gilead Sciences Inc. - Key customers
  • 66: Gilead Sciences Inc. - Segment focus
  • 67: GlaxoSmithKline Plc - Overview
  • 68: GlaxoSmithKline Plc - Business segments
  • 69: GlaxoSmithKline Plc - Key offerings
  • 70: GlaxoSmithKline Plc - Key customers
  • 71: GlaxoSmithKline Plc - Segment focus
  • 72: Maruho Co. Ltd. - Overview
  • 73: Maruho Co. Ltd. - Product and service
  • 74: Maruho Co. Ltd. - Key offerings
  • 75: Maruho Co. Ltd. - Key customers
  • 76: Maruho Co. Ltd. - Segment focus
  • 77: Merck & Co. Inc. - Overview
  • 78: Merck & Co. Inc. - Business segments
  • 79: Merck & Co. Inc. - Key offerings
  • 80: Merck & Co. Inc. - Key customers
  • 81: Merck & Co. Inc. - Segment focus
  • 82: Mylan NV - Overview
  • 83: Mylan NV - Business segments
  • 84: Mylan NV - Key offerings
  • 85: Mylan NV - Key customers
  • 86: Mylan NV - Segment focus
  • 87: Novartis AG - Overview
  • 88: Novartis AG - Business segments
  • 89: Novartis AG - Key offerings
  • 90: Novartis AG - Key customers
  • 91: Novartis AG - Segment focus
  • 92: Teva Pharmaceutical Industries Ltd. - Overview
  • 93: Teva Pharmaceutical Industries Ltd. - Business segments
  • 94: Teva Pharmaceutical Industries Ltd. - Key offerings
  • 95: Teva Pharmaceutical Industries Ltd. - Key customers
  • 96: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations